TGIA, Inc.
Update:2026/01/07
Industries
Main Industry
Biotechnology
Main Product/Service
TGIA offers high-throughput next-generation and third-generation sequencing services in Taiwan, utilising industry-grade systems such as Illumina NovaSeq X Plus, NovaSeq 6000 and PacBio Sequel IIe.
Their service portfolio spans whole genome sequencing a
Their service portfolio spans whole genome sequencing a
Founded Year
2017
Unified Business No.
52608581
Status
Active
Number of Employees
0
Total Paid-in
Capital
269,241,370 (NT$)
Location of Company
Taiwan
, Hsinchu County
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE. Exit status refers to various situations, including emerging stock exchanges (e.g., potential exits), mergers and acquisitions (M&A), and IPOs. The overseas development countries are collected through information provided by startups themselves and the information filled in when registering for matchmaking events. Therefore, the information cannot be updated in real time. If you wish to make corrections, please email findit.tier@gmail.com. Thank you.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person. Please do not contact this platform for company inquiries.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Taiwan Genomic Industry Alliance Inc. (TGIA) is a Taiwan-based company located in Nankang Software Park and, since 2022, headquartered in Hsinchu Biomedical Science Park as its operational and R&D center. Established under the guidance of the “Asia Pacifi